Mifepristone DOSAGE, Cas No.84371-65-3, Medicines in India, consumers, healthcare professionals,Side Effects, Interactions, Information, Overdosage, community, exporters, Machinery, Providers, api lists in India, wholesalers, biotech, active pharma

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Mifepristone Taj API

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Mifepristone Manufacturers in India Suppliers Mifepristone Dossage Exporters Distributors Mifepristone api active pharmaceuticals ingredients Mifepristone manufacturers Side Effects bulk drugs raw material Dossage Mifepristone companies Side Effects Dossage Importers Mifepristone Dossage Mifepristone Exporters Mifepristone exporters Dossage FDA Dossage Mifepristone Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Mifepristone manufacturing pharmaceutical drugs pharmaceutical intermediates Mifepristone pharmaceutical chemicals pharmaceutical raw materials Mifepristone active pharmaceutical ingredients Mifepristone committee active pharmaceutical ingredients manufacturer Mifepristone Active Pharmaceutical Ingredients manufacturer Mifepristone exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Mifepristone, Mifepristone manufacturer India, Mifepristone product, Mifepristone products, Api preparation, Certificate of Analysis API manufacturer product, Mifepristone anti ulcer product, Certificate of Origin COA Mifepristone COS Mifepristone, pharmaceutical generic, pharmaceutical drug, medical, Mifepristone pharma healthcare, pharma patents, contract MSDS manufacturing Trader Mifepristone pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Mifepristone expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Mifepristone DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Mifepristone ingredients, api, HIV Mifepristone, tablets, capsules, syrup & protein Mifepristone powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Mifepristone gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Mifepristone WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

Chemical Taj Pharmaceuticals Ltd.

HOME >> API >> API List 2 >> Mifepristone >> Dosage

DOSAGE
Mifepristone CAS Number 84371-65-3

Treatment with Mifeprex and misoprostol for the termination of pregnancy requires three office visits by the patient. Mifeprex should be prescribed only by physicians who have read and understood the prescribing information. Mifeprex may be administered only in a clinic, medical office, or hospital, by or under the supervision of a physician, able to assess the gestational age of an embryo and to diagnose ectopic pregnancies. Physicians must also be able to provide surgical intervention in cases of incomplete abortion or severe bleeding, or have made plans to provide such care through others, and be able to assure patient access to medical facilities equipped to provide blood transfusions and resuscitation, if necessary.
Day One: Mifeprex Administration

Patients must read the MEDICATION GUIDE and read and sign the PATIENT AGREEMENT before Mifeprex is administered.

Three 200 mg tablets (600 mg) of Mifeprex are taken in a single oral dose.
Day Three: Misoprostol Administration
The patient returns to the health care provider two days after ingesting Mifeprex. Unless abortion has occurred and has been confirmed by clinical examination or ultrasonographic scan, the patient takes two 200 μg tablets (400 μg) of misoprostol orally.
Day 14: Post-Treatment Examination

Patients will return for a follow-up visit approximately 14 days after the administration of Mifeprex. This visit is very important to confirm by clinical examination or ultrasonographic scan that a complete termination of pregnancy has occurred.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE >>

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin	Gemcitabine Hcl	Glimepiride	Granisetron Hcl	Ibandronate Sodium	Imatinib Mesylate	Irbesartan	Irinotecan Hcl	Isradipine	Lamotrigine
Lercanidipine	Letrozole	Losartan Potassium	Loteprednol Etabonate	Magnesium Valproate	Meloxicam	Memantine Hcl	Mesalazine	Metamizol Magnesium	Metaxalone
Metformin Hcl	Metoprolol Tartrate	Mifepristone	Mirtazapine	Modafinil	Mometasone Furoate	Naltrexone Hcl	Netaglinide

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.